Lab evolution recreates COVID's path to omicron in months, reveals key conditions - Phys.org

Lab evolution recreates COVID's path to omicron in months, reveals key conditions  Phys.org

Steric hindrance of antibody binding in an Omicron spike fusion intermediate - Nature

Steric hindrance of antibody binding in an Omicron spike fusion intermediate  Nature

Omicron-adapted COVID vaccines may reduce death, hospitalization risk - CIDRAP

Omicron-adapted COVID vaccines may reduce death, hospitalization risk  CIDRAP

Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants - Na...

Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants  Nature

Long-COVID prevalence may vary by COVID-19 variant, time since infection - CIDRAP

Long-COVID prevalence may vary by COVID-19 variant, time since infection  CIDRAP

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization ...

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern  World Health Organization (WHO)

Paxlovid reduces serious risks from Omicron variants - National Institutes of Health (.gov)

Paxlovid reduces serious risks from Omicron variants  National Institutes of Health (.gov)

A Bivalent Omicron-Containing Booster Vaccine against Covid-19 - The New England Journal of Medicine

A Bivalent Omicron-Containing Booster Vaccine against Covid-19  The New England Journal of Medicine

Delta and Omicron Variants Partially Evaded COVID-19 Vaccines, Study Indicates - University of Miami

Delta and Omicron Variants Partially Evaded COVID-19 Vaccines, Study Indicates  University of Miami

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron e...

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study  The Lancet

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021 - Centers for Disease ...

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021  Centers for Disease Control and Prevention | CDC (.gov)

Update on Omicron - World Health Organization (WHO)

Update on Omicron  World Health Organization (WHO)

COVID-19 vaccines induce immune response to Omicron - National Institutes of Health (.gov)

COVID-19 vaccines induce immune response to Omicron  National Institutes of Health (.gov)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection - The New England Journ...

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection  The New England Journal of Medicine

A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and patho...

A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity  Nature

Statement on Omicron sublineage BA.2 - World Health Organization (WHO)

Statement on Omicron sublineage BA.2  World Health Organization (WHO)

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant - The New England Journal ...

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant  The New England Journal of Medicine

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time - National Institutes of...

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time  National Institutes of Health (.gov)

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant - Nature

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant  Nature

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron - Nature

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron  Nature

One year since the emergence of COVID-19 virus variant Omicron - World Health Organization (WHO)

One year since the emergence of COVID-19 virus variant Omicron  World Health Organization (WHO)

Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy - Nature

Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy  Nature

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies - Nature

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies  Nature

T cell responses to SARS-CoV-2 spike cross-recognize Omicron - Nature

T cell responses to SARS-CoV-2 spike cross-recognize Omicron  Nature

An Update on Omicron Subvariants - Johns Hopkins Bloomberg School of Public Health

An Update on Omicron Subvariants  Johns Hopkins Bloomberg School of Public Health

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras  The New England Journal of Medicine

The Omicron Booster: Your Questions Answered - Yale Medicine

The Omicron Booster: Your Questions Answered  Yale Medicine

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant - The New England Jo...

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant  The New England Journal of Medicine

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge - The New England Journal ...

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge  The New England Journal of Medicine

‘Killer’ immune cells still recognize Omicron variant - Nature

‘Killer’ immune cells still recognize Omicron variant  Nature

Omicron: 10 things to know about the very contagious COVID-19 variant - University of California ...

Omicron: 10 things to know about the very contagious COVID-19 variant  University of California - Davis Health

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections - The New England...

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections  The New England Journal of Medicine

Omicron has caused higher increase in U.S. daily death count than delta variant - PBS

Omicron has caused higher increase in U.S. daily death count than delta variant  PBS

Antibody Response to Omicron BA.4–BA.5 Bivalent Booster - The New England Journal of Medicine

Antibody Response to Omicron BA.4–BA.5 Bivalent Booster  The New England Journal of Medicine

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization - Nature

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization  Nature

Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation - Nature

Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation  Nature

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex ...

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex  Science | AAAS

Where did Omicron come from? Three key theories - Nature

Where did Omicron come from? Three key theories  Nature

TAG-VE statement on Omicron sublineages BQ.1 and XBB - World Health Organization (WHO)

TAG-VE statement on Omicron sublineages BQ.1 and XBB  World Health Organization (WHO)

Effects of Vaccination and Previous Infection on Omicron Infections in Children - The New England...

Effects of Vaccination and Previous Infection on Omicron Infections in Children  The New England Journal of Medicine

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant - The New England Jou...

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant  The New England Journal of Medicine

Modeling transmission of SARS-CoV-2 Omicron in China - Nature

Modeling transmission of SARS-CoV-2 Omicron in China  Nature

COVID-19’s BA.4 and BA.5 Omicron subvariants: 12 questions, answered - UT MD Anderson

COVID-19’s BA.4 and BA.5 Omicron subvariants: 12 questions, answered  UT MD Anderson

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron - The New England Journal of M...

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron  The New England Journal of Medicine

Botswana lab known for identifying Omicron variant receives new recognition - Harvard T.H. Chan S...

Botswana lab known for identifying Omicron variant receives new recognition  Harvard T.H. Chan School of Public Health

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - The New Engla...

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1  The New England Journal of Medicine

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution - Nature

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution  Nature

What You Need to Know About XBB.1.5, the Latest Omicron Variant - Johns Hopkins Bloomberg School ...

What You Need to Know About XBB.1.5, the Latest Omicron Variant  Johns Hopkins Bloomberg School of Public Health

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination - The New England J...

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination  The New England Journal of Medicine

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters - Nature

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters  Nature

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel - The New England Journal of Me...

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel  The New England Journal of Medicine

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa ...

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa  The New England Journal of Medicine

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants - The New England Journ...

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants  The New England Journal of Medicine

Omicron: increased transmissibility and decreased pathogenicity - Nature

Omicron: increased transmissibility and decreased pathogenicity  Nature

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting - Nature

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting  Nature

BNT162b2 Protection against the Omicron Variant in Children and Adolescents - The New England Jou...

BNT162b2 Protection against the Omicron Variant in Children and Adolescents  The New England Journal of Medicine

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 - Nature

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5  Nature

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 - The New Engla...

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5  The New England Journal of Medicine

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates - Nature

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates  Nature

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa - Nature

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa  Nature

What doctors want patients to know about the BA.2 Omicron subvariant - American Medical Association

What doctors want patients to know about the BA.2 Omicron subvariant  American Medical Association

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar - The New England J...

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar  The New England Journal of Medicine

Beyond Omicron - Harvard Medical School

Beyond Omicron  Harvard Medical School

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB - The New England Journal...

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB  The New England Journal of Medicine

Durability of XBB.1.5 Vaccines against Omicron Subvariants - The New England Journal of Medicine

Durability of XBB.1.5 Vaccines against Omicron Subvariants  The New England Journal of Medicine

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6 - The New England Journal of Medicine

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6  The New England Journal of Medicine

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization - Nature

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization  Nature

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies - Nature

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies  Nature

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection - Nature

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection  Nature

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75 - The New England Journal of ...

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75  The New England Journal of Medicine

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants - Nature

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants  Nature

Current vaccines teach T cells to fight Omicron - La Jolla Institute

Current vaccines teach T cells to fight Omicron  La Jolla Institute

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron - Nature

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron  Nature

Effectiveness of Bivalent Boosters against Severe Omicron Infection - The New England Journal of ...

Effectiveness of Bivalent Boosters against Severe Omicron Infection  The New England Journal of Medicine

Antibodies recognize new SARS-CoV-2 Omicron variant after booster - National Institutes of Health...

Antibodies recognize new SARS-CoV-2 Omicron variant after booster  National Institutes of Health (.gov)

COVID reinfections surge during Omicron onslaught - Nature

COVID reinfections surge during Omicron onslaught  Nature

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo - Nature

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo  Nature

Omicron Boosters and Flu Shots: What to Know This Fall - Cedars-Sinai

Omicron Boosters and Flu Shots: What to Know This Fall  Cedars-Sinai

Durability of Bivalent Boosters against Omicron Subvariants - The New England Journal of Medicine

Durability of Bivalent Boosters against Omicron Subvariants  The New England Journal of Medicine

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection - The New England...

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection  The New England Journal of Medicine

Sick and Tired: Omicron Overwhelms California Workers - CalMatters

Sick and Tired: Omicron Overwhelms California Workers  CalMatters

Antibody evasion properties of SARS-CoV-2 Omicron sublineages - Nature

Antibody evasion properties of SARS-CoV-2 Omicron sublineages  Nature

Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal...

Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue  Nature

Protection against Omicron from Vaccination and Previous Infection in a Prison System - The New E...

Protection against Omicron from Vaccination and Previous Infection in a Prison System  The New England Journal of Medicine

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons - The...

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons  The New England Journal of Medicine

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection - Nature

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection  Nature

Omicron thwarts some of the world’s most-used COVID vaccines - Nature

Omicron thwarts some of the world’s most-used COVID vaccines  Nature

Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant...

Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant  Nature

Omicron booster shots are coming—with lots of questions - Science | AAAS

Omicron booster shots are coming—with lots of questions  Science | AAAS

What you need to know about the BA.5 omicron variant - Mayo Clinic News Network

What you need to know about the BA.5 omicron variant  Mayo Clinic News Network

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity - Nature

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity  Nature

COVID-19: How the Omicron variant affects Europe? - unric

COVID-19: How the Omicron variant affects Europe?  unric

Omicron-fuelled COVID-19 surge in Africa plateaus - WHO | Regional Office for Africa

Omicron-fuelled COVID-19 surge in Africa plateaus  WHO | Regional Office for Africa

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 - The Lancet

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2  The Lancet

Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants - Nature

Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants  Nature

People who catch Omicron are less likely to get Long Covid - Science | AAAS

People who catch Omicron are less likely to get Long Covid  Science | AAAS

CDC recommends new booster shots to fight omicron - NPR

CDC recommends new booster shots to fight omicron  NPR

Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 - Nature

Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5  Nature

Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later ...

Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants  Science | AAAS

Omicron subvariant BA.5 efficiently infects lung cells - Nature

Omicron subvariant BA.5 efficiently infects lung cells  Nature